ETF Managers Group, LLC Icosavax, Inc. Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

A detailed history of ETF Managers Group, LLC transactions in Icosavax, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 12,961 shares of ICVX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,961

Holding current value

% of portfolio

0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$5.62 - $11.51 $72,840 - $149,181	12,961 New	12,961 $75,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $9.21 $2,413 - $7,193	-781 Reduced 6.22%	11,770 $37,000
Q2 2022 Aug 15, 2022	BUY	$5.7 - $10.33 $4,035 - $7,313	708 Added 5.98%	12,551 $88,000
Q1 2022 May 13, 2022	BUY	$4.41 - $22.5 $194 - $990	44 Added 0.37%	11,843 $63,000
Q4 2021 Feb 14, 2022	SELL	$21.07 - $34.98 $53,981 - $89,618	-2,562 Reduced 17.84%	11,799 $272,000
Q3 2021 Nov 15, 2021	BUY	$24.85 - $40.25 $356,870 - $578,030	14,361 New	14,361 $421,000

Others Institutions Holding ICVX

# of Institutions

Shares Held

1.37M

Call Options Held

Put Options Held

Nano Dimension, Inc.

1.36M
Shares

$0
17.45% of portfolio

View Full List

About Icosavax, Inc.

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

More about ICVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account